November 12 (SeeNews) - Serbia has agreed the delivery of 1.8 million units of the COVID-19 vaccine developed by US-based pharmaceutical company Pfizer and German biotechnology company BioNTech by the end of 2021, Serbian president Aleksandar Vucic said on Thursday.